Research output: Contribution to journal › Article › peer-review
Hyaluronan/B12-chitosan polyelectrolyte complex for oral colistin administration. / Dubashynskaya, N.V.; Bokatyi, A.N.; Sall, T.S.; Egorova, T.S.; Demyanova, E.V.; Dubrovskii, Y.A.; Murashko, E.A.; Anufrikov, Y.A.; Shasherina, A.Y.; Vlasova, E.N.; Skorik, Y.A.
In: International Journal of Biological Macromolecules, Vol. 263, 130177, 01.04.2024.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Hyaluronan/B12-chitosan polyelectrolyte complex for oral colistin administration
AU - Dubashynskaya, N.V.
AU - Bokatyi, A.N.
AU - Sall, T.S.
AU - Egorova, T.S.
AU - Demyanova, E.V.
AU - Dubrovskii, Y.A.
AU - Murashko, E.A.
AU - Anufrikov, Y.A.
AU - Shasherina, A.Y.
AU - Vlasova, E.N.
AU - Skorik, Y.A.
N1 - Export Date: 04 March 2024; Cited By: 0; CODEN: IJBMD
PY - 2024/4/1
Y1 - 2024/4/1
N2 - Polyelectrolyte complexes (PECs) based on polysaccharides, including hyaluronic acid (HA) and chitosan (CS), are promising delivery systems for antimicrobial agents, including oral administration of the peptide antibiotic colistin (CT). Modification of CS with different targeting ligands to improve intestinal permeability is a suitable way to improve the oral bioavailability of polyelectrolyte particles. This study describes the procedure for obtaining CT-containing PECs based on HA and CS modified with cyanocobalamin (vitamin B12). In this case, vitamin B12 is used as a targeting ligand because it is absorbed in the ileum via specific transporter proteins. The resulting PECs had a hydrodynamic size of about 284 nm and a positive ζ-potential of about 26 mV; the encapsulation efficiency was 88.2 % and the CT content was 42.2 μg/mg. The developed systems provided a two-phase drug release: about 50 % of the CT was released in 0.5–1 h, and about 60 % of the antibiotic was cumulatively released in 5 h. The antimicrobial activity of encapsulated CT was maintained at the same level as the pure drug for at least 24 h (minimum inhibitory concentration against Pseudomonas aeruginosa was 2 μg/mL for both). In addition, the apparent permeability coefficient of CT in the PEC formulation was 2.4 × 10−6 cm/s. Thus, the incorporation of CT into HA- and vitamin B12-modified CS-based PECs can be considered as a simple and convenient method to improve the oral delivery of CT. © 2024
AB - Polyelectrolyte complexes (PECs) based on polysaccharides, including hyaluronic acid (HA) and chitosan (CS), are promising delivery systems for antimicrobial agents, including oral administration of the peptide antibiotic colistin (CT). Modification of CS with different targeting ligands to improve intestinal permeability is a suitable way to improve the oral bioavailability of polyelectrolyte particles. This study describes the procedure for obtaining CT-containing PECs based on HA and CS modified with cyanocobalamin (vitamin B12). In this case, vitamin B12 is used as a targeting ligand because it is absorbed in the ileum via specific transporter proteins. The resulting PECs had a hydrodynamic size of about 284 nm and a positive ζ-potential of about 26 mV; the encapsulation efficiency was 88.2 % and the CT content was 42.2 μg/mg. The developed systems provided a two-phase drug release: about 50 % of the CT was released in 0.5–1 h, and about 60 % of the antibiotic was cumulatively released in 5 h. The antimicrobial activity of encapsulated CT was maintained at the same level as the pure drug for at least 24 h (minimum inhibitory concentration against Pseudomonas aeruginosa was 2 μg/mL for both). In addition, the apparent permeability coefficient of CT in the PEC formulation was 2.4 × 10−6 cm/s. Thus, the incorporation of CT into HA- and vitamin B12-modified CS-based PECs can be considered as a simple and convenient method to improve the oral delivery of CT. © 2024
UR - https://www.mendeley.com/catalogue/bdd53741-f061-304f-8214-0382f904480f/
U2 - 10.1016/j.ijbiomac.2024.130177
DO - 10.1016/j.ijbiomac.2024.130177
M3 - статья
VL - 263
JO - International Journal of Biological Macromolecules
JF - International Journal of Biological Macromolecules
SN - 0141-8130
M1 - 130177
ER -
ID: 117311980